10 Hot Stocks to Watch — Wednesday, September 23, 2026

Rocket Lab rallied 8.24% today, breaking above a key technical trendline amid mounting defense contracts and an Iridium partnership that CEO Peter Beck positioned alongside SpaceX and Amazon's spectrum plays. Options traders are heavily long, with a 17.83 call-to-put ratio and 10,880 contracts flooding the $75 strike for September 2026 expiry. Wall Street sees valuation upside, though profitability timelines remain extended; watch $75 as near-term resistance.

Moderna surged to $182.56 today, extending its remarkable cancer-vaccine-driven rally as Wall Street remains divided on valuation. Options traders are aggressively positioning for further upside, with a 4.28 call-to-put ratio and over 25,000 contracts trading in the $200 call expiring September 25—a level 9.5% above current price. Analysts warn the stock looks expensive relative to near-term sales, yet momentum and co-founder Bob Langer's AI-drug advisory role keep narrative tailwinds intact. Watch the $200 strike through Friday's expiry.

General Motors dropped 5.1% today to $82.20, extending pressure from China trade concerns despite a $700M Pentagon contract expansion and solid fundamentals. Yet options markets are flashing a contrarian signal: call-to-put ratio of 2.52 and heavy positioning in 2026 call spreads ($83–$91 strikes) suggest institutional buyers are accumulating on weakness. Defense revenue diversification and battery recycling advances provide near-term catalysts, with September 2026 $85 calls drawing 419 contracts.

Micron surged 5% to $1,096 on renewed optimism around agentic AI applications and Meta's infrastructure push, extending its remarkable recovery from $154 lows. Options traders are aggressively positioning for upside, with a 5.28 call-to-put ratio and heavy volume in $1,100 calls expiring late September—suggesting conviction that the stock can break above its $1,255 52-week high. However, legendary short-seller Michael Burry cautioned that memory producers face downside risk as supply normalizes, a note of caution amid otherwise buoyant technicals and $41.5B quarterly revenues that underscore AI's staying power.

Adobe shares tumbled 4.52% today, extending a year-to-date decline of roughly 32% despite a recent 28% three-month bounce. The selloff mirrors broader software sector headwinds as major players discount AI offerings to compete with Anthropic and OpenAI, pressuring margin recovery narratives. Options markets show mixed conviction—heavy put flow at $210–$230 through October 2026 signals downside hedging, while $245–$255 calls remain active through September. Watch the $238 level as support; a breach could retest $220.

JPMorgan Chase tumbled 3.42% to $340 as Meta's new AI agent and competitive pressure from Vanguard-backed platforms overshadowed a fresh $20 billion sovereign wealth partnership with QIA. The selloff signals investor concern that AI-driven customer friction elimination poses a structural threat to banking's high-margin advisory model. Options markets paint a sharply bullish picture: call-to-put ratio of 3.31 with heavy positioning in $345 and $350 strikes expiring September 2026, suggesting institutional buyers view the $340 level as tactical support and see upside to $345–$350 within 12 months.

Arm Holdings jumped 3.19% to $333.20 as investors reassess the chipmaker's role in the agentic AI buildout, with CEO Haas signaling confidence in hitting $2B AGI CPU targets. The options market is decidedly bullish: call volume towers over puts at a 4.19 ratio, with heavy positioning in $365 and $350 calls expiring September 2026—suggesting conviction the stock can run another 10% higher. Valuation concerns linger among analysts, but momentum and data-center CPU demand tailwinds are keeping the bid intact.

VXX fell 3.05% today as broad index volatility declined, though macro uncertainty around Middle East tensions and sticky inflation continues to fuel hedging activity. Options markets show aggressive bullish positioning, with a 3.70 call-to-put ratio and nearly 3,900 contracts in the $20 calls expiring October 2026, suggesting traders are betting on sustained volatility spikes. Watch the $20 level as a near-term resistance; geopolitical risk and upcoming FOMC decisions could reignite demand for volatility hedges.

Bank of America fell 3.04% today as broader banking sector weakness ripples through Wall Street, driven by AI-fueled fintech disruption and Treasury yield dynamics pressuring net interest margins. Options markets show defensive positioning: 37,109 contracts of $57 puts expiring Sept. 25 traded ITM, while call volume trails significantly at 19,786 for the same strike. Watch the $55 level—heavy October put interest there suggests institutional hedging ahead of Q3 earnings, with Treasury moves and Fed policy clarity likely to dictate near-term direction.

BioNTech rose 2.93% to $100.87 following positive Phase 3 lung cancer trial results showing its therapy nearly doubled median overall survival versus chemotherapy. Options markets are flashing bullish conviction: a 5.24 call-to-put ratio reflects heavy December and January call buying, with 268 contracts of $110 calls and 257 of $130 calls trading unusually high volume. The stock trades well below 52-week highs near $124, leaving room for a retest if clinical momentum sustains into year-end.